- Title
- Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium
- Creators
- C. H. Meyer - Emory UniversityZ. Grady - Emory UniversityR. N. Smith - Grady Health SystemT. P. Moran - Emory UniversityM. Rowh - Grady Health SystemA. Zhang - University of Maryland School of MedicineM. N. Harfouche - University of Maryland, BaltimoreP. Greiffenstein - LSU School of MedicineS. Trinh - LSU School of MedicineK. Inaba - Keck Hospital of USCN. Nekooei - Keck Hospital of USCD. M. Filiberto - University of Tennessee Health Science CenterC. E. Jones Sayyid - University of Tennessee Health Science CenterA. GutierrezJ. Meizoso - University of MiamiW. B. Risinger - University of Louisville HospitalJ. W. Smith - University of Louisville HospitalC. L. Jacovides - Temple University HospitalE. D. Trausch - Temple University HospitalA. G. McNickle - Kirk Kerkorian School of Medicine at UNLVA. Kumar - Kirk Kerkorian School of Medicine at UNLVR. L. Choron - Johnson UniversityS. W. Ross - Carolinas Medical CenterV. C. Sanderfer - Carolinas Medical CenterJ. D. Sciarretta - Grady Health SystemJ. H. Nguyen - Grady Health System
- Publication Details
- The American surgeon, Vol.91(9), pp.1484-1491
- Number of pages
- 8
- Academic Unit
- Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Trauma & Surgical Critical Care Services
- Language
- English
- Resource Type
- Journal article
- PMID
- 40614227
- Record Identifier
- 991032795895902976
Journal article
Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium
The American surgeon, Vol.91(9), pp.1484-1491
2025-09-01
PMID: 40614227
Metrics
1 Record Views